Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19) clinical trial (NCT04332094). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for COVID-19?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19) clinical trial (NCT04332094). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my hospital stay look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19) clinical trial (NCT04332094). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19) clinical trial (NCT04332094). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if I experience side effects from the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19) clinical trial (NCT04332094). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Clinical Trial of the Use of Tocilizumab for Treatment of SARS-CoV-2 Infection (COVID-19) clinical trial (NCT04332094). Contact the study team or your healthcare provider for specific answers.

What this study is about